当前位置:首页 - 行情中心 - 罗欣药业(002793) - 财务分析 - 现金流量表

罗欣药业

(002793)

  

流通市值:54.62亿  总市值:54.71亿
流通股本:10.86亿   总股本:10.88亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,245,971,833.27645,619,022.372,408,247,579.751,779,297,706.49
  收到的税费返还1,985,419.74388,168.111,873,125.329,161,984.9
  收到其他与经营活动有关的现金118,743,992.8923,559,577.3983,422,325.6877,797,825.27
  经营活动现金流入小计1,366,701,245.9669,566,767.862,503,543,030.751,866,257,516.66
  购买商品、接受劳务支付的现金261,481,91694,509,256.35809,620,562.4544,225,885.69
  支付给职工以及为职工支付的现金315,039,515.42154,613,077.37637,735,762.17472,354,987.52
  支付的各项税费89,565,565.4349,822,821.36113,912,696.8590,852,415.66
  支付其他与经营活动有关的现金482,721,870.57214,046,484.11,100,120,945.21921,287,743.78
  经营活动现金流出小计1,148,808,867.42512,991,639.182,661,389,966.632,028,721,032.65
  经营活动产生的现金流量净额217,892,378.48156,575,128.68-157,846,935.88-162,463,515.99
二、投资活动产生的现金流量:
  收回投资收到的现金--10,900,0008,800,000
  取得投资收益收到的现金--73,027.8915,356.8
  处置固定资产、无形资产和其他长期资产收回的现金净额511,346.35188,680.655,316,143.152,686,181.13
  处置子公司及其他营业单位收到的现金净额8,350,651.163,753,026101,652,756.52101,652,756.52
  收到的其他与投资活动有关的现金450,000450,0001,873,636.141,873,636.14
  投资活动现金流入小计9,311,997.514,391,706.65119,815,563.7115,027,930.59
  购建固定资产、无形资产和其他长期资产支付的现金12,254,247.626,109,895.53115,350,874.9890,864,625.59
  投资支付的现金4,000,0004,000,0005,800,0005,800,000
  支付其他与投资活动有关的现金3,889,062.71---
  投资活动现金流出小计20,143,310.3310,109,895.53121,150,874.9896,664,625.59
  投资活动产生的现金流量净额-10,831,312.82-5,718,188.88-1,335,311.2818,363,305
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,637,3503,637,350--
  其中:子公司吸收少数股东投资收到的现金3,637,3503,637,350--
  取得借款收到的现金323,500,000228,000,000933,671,406.95716,304,007.11
  收到其他与筹资活动有关的现金241,504,242.96115,885,1321,155,485,591.09721,500,000
  筹资活动现金流入小计568,641,592.96347,522,4822,089,156,998.041,437,804,007.11
  偿还债务支付的现金579,373,287.5473,000,000820,567,571.32598,573,468.01
  分配股利、利润或偿付利息支付的现金23,963,348.7514,993,753.8162,171,581.0347,708,610.46
  其中:子公司支付给少数股东的股利、利润--980,000980,000
  支付其他与筹资活动有关的现金265,541,493.7378,582,951.451,340,549,180.05889,307,455.73
  筹资活动现金流出小计868,878,129.98566,576,705.262,223,288,332.41,535,589,534.2
  筹资活动产生的现金流量净额-300,236,537.02-219,054,223.26-134,131,334.36-97,785,527.09
四、汇率变动对现金及现金等价物的影响-1,277,356.5844,602.692,761,431.21,608,300.27
五、现金及现金等价物净增加额-94,452,827.94-68,152,680.77-290,552,150.32-240,277,437.81
  加:期初现金及现金等价物余额289,389,415.42289,389,415.42579,941,565.74579,941,565.74
  期末现金及现金等价物余额194,936,587.48221,236,734.65289,389,415.42339,664,127.93
补充资料:
  净利润21,996,782--1,052,258,630.89-
  资产减值准备-43,055,461.79-314,834,673.36-
  固定资产和投资性房地产折旧76,716,221.45-152,231,787.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧76,716,221.45-152,231,787.14-
  无形资产摊销23,140,233.99-40,538,792.29-
  长期待摊费用摊销8,492,308.2-5,809,181.62-
  处置固定资产、无形资产和其他长期资产的损失-4,276,148.66--240,869.31-
  固定资产报废损失1,722.53-4,595,962.57-
  公允价值变动损失--213,130,913.8-
  财务费用31,473,184.05-62,289,130.59-
  投资损失-857,350.34-3,453,844.64-
  递延所得税15,261,871.78-97,532,390.11-
  其中:递延所得税资产减少18,595,087.97-97,759,593.81-
    递延所得税负债增加-3,333,216.19--227,203.7-
  存货的减少46,437,682.22--79,286,885.15-
  经营性应收项目的减少224,462,178.82--17,520,790.27-
  经营性应付项目的增加-200,269,102.54-81,457,981.73-
  其他13,318,722.52-2,570,459.29-
  现金的期末余额194,936,587.48-289,389,415.42-
  减:现金的期初余额289,389,415.42-579,941,565.74-
  现金及现金等价物的净增加额-94,452,827.94--290,552,150.32-
公告日期2025-08-282025-04-222025-04-222024-10-30
审计意见(境内)标准无保留意见
TOP↑